Home > Journals > Minerva Cardioangiologica > Past Issues > Minerva Cardioangiologica 2012 October;60(5) > Minerva Cardioangiologica 2012 October;60(5):491-505

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

MINERVA CARDIOANGIOLOGICA

A Journal on Heart and Vascular Diseases


Official Journal of the Italian Society of Angiology and Vascular Pathology
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,752


eTOC

 

  INTERVENTIONAL INNOVATIONS


Minerva Cardioangiologica 2012 October;60(5):491-505

language: English

Left main and bifurcation stenting

Carrié D.

CHU Toulouse Rangueil, Toulouse, France


PDF  


Coronary artery bypass graft (CABG) is considered as the gold standard treatment of unprotected left main coronary artery disease. Over the last 10 years, improvement in stent technology and operators experience explained the increased number of reports on the results of percutaneous coronary interventions for the treatment of left main (LM) coronary artery lesion particularly in the distal part of the trunk. Patient selection for bifurcation stenting is fundamental and directly impacts the clinical outcome. Many trials are conducted using bifurcated stenting technology. Further randomized trials must be conducted to precise the indications of both techniques (CABG-PCI) of revascularization in the treatment of LM disease.

top of page

Publication History

Cite this article as

Corresponding author e-mail

carrie.didier@chu-toulouse.fr